Processes of preparing mrna-loaded lipid nanoparticles
AssigneeTranslate Bio, Inc.
InventorsShrirang Karve, Ashish Sarode, Frank DeRosa
Life of this patent
Estimating the term…
Abstract
The present invention provides an improved process for lipid nanoparticle formulation and mRNA encapsulation. In some embodiments, the present invention provides a process of encapsulating messenger RNA (mRNA) in lipid nanoparticles comprising a step of mixing a suspension of preformed lipid nanoparticles and mRNA.
Claims35
A process of encapsulating messenger RNA (mRNA) in preformed empty lipid nanoparticles (LNPs), wherein the lipid component of the LNPs comprises or consists of a cationic lipid, a non-cationic lipid, a PEG-modified lipid, and optionally cholesterol and said process comprises the following steps:
- adding a first volume of a solution comprising the mRNA to a suspension comprising the preformed empty LNPs such that a mixture comprising LNPs encapsulating the mRNA is formed;
- adding one or more additional volumes of the solution comprising the mRNA to the mixture obtained in the preceding step until a desired molar ratio of cationic lipid to mRNA is achieved.
3-8. (canceled)
10-16. (canceled)
18-22. (canceled)
A process of encapsulating messenger RNA (mRNA) in preformed empty lipid nanoparticles (LNPs), wherein the lipid component of the LNPs comprises or consists of a cationic lipid, a non-cationic lipid, a PEG-modified lipid, and optionally cholesterol and said process comprises the following steps:
- adding a first volume of a suspension comprising the preformed empty LNPs to a solution comprising the mRNA such that a mixture comprising LNPs encapsulating the mRNA is formed;
- adding one or more additional volumes of the suspension comprising the preformed empty LNPs to the mixture obtained in the preceding step until a desired molar ratio of cationic lipid to mRNA is achieved.
25-29. (canceled)
31-37. (canceled)
39-43. (canceled)
45-49. (canceled)
51-60. (canceled)
62-74. (canceled)
A method of manufacturing a lipid nanoparticle (LNP) composition, the method comprising:
- mixing a first set of preformed empty lipid nanoparticles (LNPs) comprising a first cationic lipid, a first non-cationic lipid, a first PEG-modified lipid, and optionally cholesterol with mRNA under conditions that allow encapsulation of the mRNA;
- combining the mRNA-encapsulating LNPs formed in step (a) with a second set of preformed empty LNPs comprising a second cationic lipid, a second non-cationic lipid, a second PEG-modified lipid, and optionally cholesterol, resulting in the LNP composition.
76-81. (canceled)
83-88. (canceled)
A composition comprising a first set of mRNA-encapsulating lipid nanoparticles (LNPs) comprising a first cationic lipid, a first non-cationic lipid, a first PEG-modified lipid, and optionally cholesterol and a second set of empty LNPs comprising a second cationic lipid, a second non-cationic lipid, a second PEG-modified lipid, and optionally cholesterol,
- wherein the first set of LNPs and the second set of LNPs are present at a ratio ranging from 20:1 to 1:20, from 10:1 to 1:10, from 5:1 to 1:5, from 3:1 to 1:3, or from 2:1 to 1:2.
92-98. (canceled)
101-102. (canceled)
A method of encapsulating messenger RNA (mRNA) into preformed empty lipid nanoparticles (LNPs) by mixing a first fluid comprising preformed empty LNPs and a second fluid comprising mRNA, wherein the lipid component of the LNPs comprises a cationic lipid, the method comprising:
- mixing, for a first time period, the first fluid at a flow rate n1 with a first portion of the second fluid at a flow rate n2 to produce a mixed fluid having a first molar ratio of cationic lipid to mRNA;
- mixing, for a second time period, the mixed fluid at a flow rate greater than n1 and a second portion of the second fluid at flow rate n2, such that the molar ratio of cationic lipid to mRNA of the resulting mixed fluid is at least 20% lower than the first molar ratio;
- and
- repeating step (b) by increasing the flow rate of the resulting mixed fluid with each repeat until a desired molar ratio of cationic lipid to mRNA is reached.
104-140. (canceled)
An apparatus for encapsulating messenger RNA (mRNA) into preformed empty lipid nanoparticles (LNPs) by mixing a first fluid comprising preformed empty LNPs and a second fluid comprising mRNA, the apparatus comprising:
- a first pump;
- a second pump;
- a mixing junction;
- an intermediary vessel;
- a first heat exchanger;
- an arrangement of LNP conduits, configured to direct the first fluid to the mixing junction via the first pump;
- an arrangement of mRNA conduits, configured to direct the second fluid to the mixing junction via the second pump, wherein the first and second fluids form a mixed fluid at the mixing junction;
- a recycle loop, configured to:
- direct the mixed fluid from the mixing junction to the first heat exchanger, and from the first heat exchanger to the intermediary vessel, and wherein the recycle loop is configurable to direct the mixed fluid from the intermediary vessel to:
- the arrangement of LNP conduits upstream of the first pump;
- or the arrangement of mRNA conduits upstream of the second pump.
142-163. (canceled)
Dependencies are inferred from the claim text.